More Good News for Pharma's Top Stock
Linkedin

More Good News for Pharma's Top Stock

Copenhagen : Denmark | Oct 22, 2012 at 5:42 PM PDT
Source: The Motley Fool
XX XX
Views: Pending
 
Novo's performance has been fueled by an incredibly concerning trend, the growing incidence of diabetes worldwide. As the leader in insulin -- a must-have for Type 1 diabetes patients and a growing need for many Type 2 diabetics -- the company is well-positioned to capitalize on this secular trend.... FULL ARTICLE AT The Motley Fool
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.